ACE and chronic kidney disease: With regards to treatment, insulin sensitizer (adjusted OR = 22.63; 95%CI = 8.12–63.08; p<0.001) and previous ACE inhibitor or angiotensin receptor blockers (adjusted OR = 2.38; 95%CI = 1.13–5.00; p<0.05) were both strongly associated with CKD stage progression.